Risk Assessment White Papers & Case Studies
-
Rapid Response To Earthquake Damage Keeps Critical Shipments Moving
5/22/2012
Following the major earthquake (8.9 on Richter scale) that struck Japan on March 11, 2011, the Fukushima Daiichi nuclear plant suffered severe damage to multiple reactors. Due to the damage at the nuclear plant and other serious damage caused by the tsunami, service to the main cities and prefectures in central Japan was dramatically curtailed.
-
Biomanufacturing Supply Chains
12/22/2011
This white paper examines the major issues with biopharmaceutical supply chains and how to balance inventory and risk optimally in the network.
-
Evolving From Cold Chain Logistics Management To Cold Chain Logistics Control
9/7/2011
Particularly for companies involved in the life sciences, the entire field of cold chain logistics has undergone significant changes in a relatively few years.
-
High Value Biologic Drugs Will Demand A Comprehensive Supply Chain
The dramatic shift in our industry from small molecule drugs to high value biopharmaceuticals is increasing the need to focus on logistics and supply chain management.
-
Extremely Sensitive Biological Asset Transfer No Problem For Marken
Roslin Cells, a world leader in the isolation of new clinical grade pluripotent stem cells for use in research and development, was moving their site from within the Roslin Biocentre in Edinburgh to a new facility housed within the new Scottish Centre for Regenerative Medicine.
-
IMP Shipments: Too Big, Too Costly, Too Bad
A client in the UK was initiating a new clinical trial, and shipping forty-two pallets of the IMP to Marken’s pharmaceutical service depot in the testing region created several challenges.
-
A 15-Minute Guide To Compliant Document Management For Life Sciences
Life Sciences quality and manufacturing organizations face three critical industry forces: increasingly stringent regulation; globalization; and virtualization of supply networks.
-
Quality Trumps Cost With Clinical Logistics Providers
Part two of Marken CEO Wes Wheeler’s ten part blog series about the changing face of Life Science Logistics in today’s fast-paced pharmaceutical industry. By Wes Wheeler, Marken
-
Scientific Standards For Ambient Temperature Profile Development
Storing and shipping highly temperature-sensitive drug products requires sophisticated packaging to ensure that the product remains safe and viable — from the manufacturing plant to the end user. By: Kenneth Maltas, Vice President of Engineering Auston Matta, Engineering Team Lead R&D Kevin O’Donnell, Technical Director D’Arcy Ryan, Director of Marketing
-
Efficiencies Of Natural Convection In Passive Pallet Shippers
Bulk transportation of temperature sensitive pharmaceuticals and biologics has become a common practice due to complex global supply chains. By Iftekhar Ahmed, Ben VanderPlas, and Stu Krupnick